Rawcliffe Adrian
SEC CIK 1555851 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences, Inc. | Dir | 0 | — | $806.6K | 6 | 2024-08-12 | 2026-08-12 |
Most active insiders at WVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| 2 | GSK plc | 10% | $27.93M | — |
| 3 | Francis Chris | See Remarks | — | $7.10M |
| 4 | Moran Kyle | CFO | — | $4.15M |
| 5 | Tan Aik Na | Dir | — | $1.83M |
| 6 | HENRY CHRISTIAN O | Dir | — | $1.37M |
| 7 | Rawcliffe Adrian | Dir | — | $806.6K |
| 8 | Verdine Gregory L. | Dir | — | $269.5K |
| 9 | Wagner Heidi L | Dir | — | $231.1K |
| 10 | CORRIGAN MARK | Dir | — | $217.3K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-13 21:00 | 2026-08-12 | WVE | Wave Life Sciences, Inc. | Rawcliffe Adrian | Dir | S - Sale | $5.29 | -12.7K | 0 | -100% | -$67.2K |
| DT | 2025-12-10 | 2025-12-08 | WVE | Wave Life Sciences, Inc. | Rawcliffe Adrian | Dir | S - Sale+OE | $15.00 | -42.0K | 12.7K | -77% | -$630.0K |
| DT | 2025-12-10 | 2025-12-08 | WVE | Wave Life Sciences, Inc. | Rawcliffe Adrian | Dir | M - OptEx | $5.97 | +42.0K | 54.7K | +331% | +$250.7K |
| T | 2025-11-14 | 2025-11-13 | WVE | Wave Life Sciences, Inc. | Rawcliffe Adrian | Dir | S - Sale | $6.79 | -16.1K | 12.7K | -56% | -$109.4K |
| D | 2025-08-13 | 2025-08-11 | WVE | Wave Life Sciences, Inc. | Rawcliffe Adrian | Dir | A - Grant | $0.00 | +12.7K | 28.8K | +79% | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Wave Life Sciences, Inc. | Rawcliffe Adrian | Dir | A - Grant | $0.00 | +16.1K | 16.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations